Imagen de portada del espectáculo Healio Minute

Healio Minute

Podcast de Healio

inglés

Tecnología y ciencia

Oferta limitada

2 meses por 1 €

Después 4,99 € / mesCancela cuando quieras.

  • 20 horas de audiolibros / mes
  • Podcasts solo en Podimo
  • Podcast gratuitos
Empezar

Acerca de Healio Minute

The latest health care news you need, when you need it. Only at Healio.

Todos los episodios

153 episodios

Portada del episodio Rheumatology Edition: Top Headlines for Week of May 4, 2026

Rheumatology Edition: Top Headlines for Week of May 4, 2026

In this edition, we look at rheumatology visits impacting reproductive health counseling, restrictive Medicare Part D coverage, and more. Read the full coverage here: Services targeting rheumatology visits increased reproductive health counseling rates 625% [https://www.healio.com/news/rheumatology/20260406/services-targeting-rheumatology-visits-increased-reproductive-health-counseling-rates-625] Medicare Part D coverage of certain rheumatoid arthritis drugs 'restrictive' [https://www.healio.com/news/rheumatology/20260413/medicare-part-d-coverage-of-certain-rheumatoid-arthritis-drugs-restrictive] DMARD treatment fails to mitigate osteoporosis in rheumatoid arthritis [https://www.healio.com/news/rheumatology/20260408/dmard-treatment-fails-to-mitigate-osteoporosis-in-rheumatoid-arthritis] FDA to 'carefully shepherd' CAR T-cell therapy trials in autoimmune, rheumatic disease [https://www.healio.com/news/rheumatology/20260409/fda-to-carefully-shepherd-car-tcell-therapy-trials-in-autoimmune-rheumatic-disease] Low pay, longer training requirements hobble pediatric rheumatology workforce numbers [https://www.healio.com/news/rheumatology/20260402/low-pay-longer-training-requirements-hobble-pediatric-rheumatology-workforce-numbers] References: Aritomi T, et al. Arthritis Rheumatol. 2026;doi:10.1002/art.70125. Healio interviews Healio interviews Kwon Y, et al. Arthritis Rheumatol. 2026;doi:10.1002/art.70132. Marcy D, et al. Arthritis Care Res. 2026;doi:10.1002/acr.80014.

4 de may de 2026 - 11 min
Portada del episodio Orthopedics Edition: Top Headlines for Week of December 29, 2025

Orthopedics Edition: Top Headlines for Week of December 29, 2025

In this edition, we look at the impact of GLP-1s on total joint replacement, the safety of NSAID's and more. Read the full coverage here: GLP-1s may have profound impact on total joint replacement [https://www.healio.com/news/orthopedics/20251208/glp1s-may-have-profound-impact-on-total-joint-replacement] NSAID use may be safe prior to total joint arthroplasty [https://www.healio.com/news/orthopedics/20251201/nsaid-use-may-be-safe-prior-to-total-joint-arthroplasty] Complication risk may be lower for revision TJA when performed in ASC [https://www.healio.com/news/orthopedics/20251120/complication-risk-may-be-lower-for-revision-tja-when-performed-in-asc] Despite improved function, patients with elbow dislocation often report long-term pain [https://www.healio.com/news/orthopedics/20251205/despite-improved-function-patients-with-elbow-dislocation-often-report-longterm-pain] Osteochondral allograft transplant may treat pediatric elbow osteochondritis dissecans [https://www.healio.com/news/orthopedics/20251215/osteochondral-allograft-transplant-may-treat-pediatric-elbow-osteochondritis-dissecans] References: Acuña AJ, et al. Paper 33. Presented at: American Association of Hip and Knee Surgeons Annual Meeting; Oct. 23-26, 2025; Dallas. Foran JRH, et al. Paper 31. Presented at: American Association of Hip and Knee Surgeons Annual Meeting; Oct. 23-26, 2025; Dallas. Healio Interviews Perkins CA, et al. Am J Sports Med. 2025;doi:10.1177/03635465251366903. Plaisier N, et al. Paper 29. Presented at: Orthopaedic Trauma Association Annual Meeting; Oct. 15-18, 2025; Phoenix.

30 de dic de 2025 - 9 min
Portada del episodio Lung Cancer Edition: Top Headlines for Week of December 15, 2025

Lung Cancer Edition: Top Headlines for Week of December 15, 2025

In this edition, immunotherapy in advanced lung cancer, updates in EGFR-mutated lung cancer and more. Read the full coverage here: VIDEO: Immunotherapy in advanced lung cancer among highlights from ESMO 2025 [https://www.healio.com/news/hematology-oncology/20251123/video-immunotherapy-in-advanced-lung-cancer-among-highlights-from-esmo-2025] VIDEO: Updates in EGFR-mutated lung cancer from ESMO 2025 [https://www.healio.com/news/hematology-oncology/20251123/video-updates-in-egfrmutated-lung-cancer-from-esmo-2025] VIDEO: DeLLphi-303 results show 'major jump in survival' for SCLC patients [https://www.healio.com/resources/oncointel-lung-cancer/expert-videos-on-lung-cancer/video-dellphi303-results-show-major-jump-in-survival-for-sclc-patients] Emphysema found during lung cancer screening raises risk for mortality [https://www.healio.com/news/pulmonology/20251121/emphysema-found-during-lung-cancer-screening-raises-risk-for-mortality] Q&A: More nonsmokers developing lung cancer due to radon exposure, air pollution [https://www.healio.com/news/hematology-oncology/20251118/qa-more-nonsmokers-developing-lung-cancer-due-to-radon-exposure-air-pollution] References · González Gutiérrez J, et al. Radiology. 2025;doi:10.1148/radiol.250949. [https://pubs.rsna.org/doi/10.1148/radiol.250949] · Healio Interviews · Healio Interviews · Healio Interviews · Paulson KG, et al. Abstract OA13.01. Presented at IASLC World Conference on Lung Cancer; Sept. 6-9, 2025; Barcelona.

18 de dic de 2025 - 10 min
Portada del episodio Orthopedics Edition: Top Headlines for Week of December 15, 2025

Orthopedics Edition: Top Headlines for Week of December 15, 2025

In this edition, we look at robotic-assisted surgery, dislocation risk in fixed-bearing THA and more. Read the full coverage here: Higher head-to-cup ratio, robotic-assisted surgery may lower dislocation rate after THA [https://www.healio.com/news/orthopedics/20251114/higher-headtocup-ratio-roboticassisted-surgery-may-lower-dislocation-rate-after-tha] Fully maximizing bearing diameter may reduce dislocation risk in fixed-bearing THA [https://www.healio.com/news/orthopedics/20251104/fully-maximizing-bearing-diameter-may-reduce-dislocation-risk-in-fixedbearing-tha] How may GLP-1s impact nutrition prior to orthopedic surgery? [https://www.healio.com/news/orthopedics/20251210/how-may-glp1s-impact-nutrition-prior-to-orthopedic-surgery] Medicare contractors propose coverage restriction of peripheral nerve block procedures [https://www.healio.com/news/orthopedics/20251125/medicare-contractors-propose-coverage-restriction-of-peripheral-nerve-block-procedures] Physician content on TikTok may guide patient education [https://www.healio.com/news/orthopedics/20251119/physician-content-on-tiktok-may-guide-patient-education] References: Expert submission Healio Interviews Healio Interviews Kobayashi JK, et al. Paper 54. Presented at: American Association of Hip and Knee Surgeons Annual Meeting; Oct. 23-26, 2025; Dallas. Wang E, et al. Maximizing bearing diameter markedly lowers dislocations in primary total hip arthroplasty. Presented at: American Association of Hip and Knee Surgeons Annual Meeting; Oct. 23-26, 2025; Dallas.

16 de dic de 2025 - 10 min
Portada del episodio Dermatology Edition: Top Headlines – Week of November 24, 2025

Dermatology Edition: Top Headlines – Week of November 24, 2025

In this edition, FDA warns complications following radiofrequency microneedling device use, chronic hand eczema considered "common" disease, and more. Read the full coverage here: Q&A: FDA warns of radiofrequency microneedling risks; here's what to know [https://www.healio.com/news/dermatology/20251103/qa-fda-warns-of-radiofrequency-microneedling-risks-heres-what-to-know] Chronic hand eczema now considered a 'common' skin disease in US [https://www.healio.com/news/dermatology/20251107/chronic-hand-eczema-now-considered-a-common-skin-disease-in-us] 'Unproven' topical estrogens for the face may bring some risks [https://www.healio.com/news/dermatology/20251105/unproven-topical-estrogens-for-the-face-may-bring-some-risks] FDA approves Restylane Lyft to treat receding chin [https://www.healio.com/news/dermatology/20251111/fda-approves-restylane-lyft-to-treat-receding-chin] References Chovatiya R, et al. Prevalence of self-reported physician diagnosis of chronic hand eczema in adults: A cross-sectional study of more than 10,000 participants in the general population – Results from the CHECK study in the United States. Presented at: Fall Clinical Dermatology Conference; Oct. 23-26, 2025; Las Vegas. Farkas E, et al J Am Acad Dermatol. 2025;doi:10.1016/j.jaad.2025.08.050. [https://linkinghub.elsevier.com/retrieve/pii/S0190962225026763] Healio Interviews Press Release [https://www.galderma.com/news/galderma-receives-us-fda-approval-restylane-lyft]

28 de nov de 2025 - 9 min
Soy muy de podcasts. Mientras hago la cama, mientras recojo la casa, mientras trabajo… Y en Podimo encuentro podcast que me encantan. De emprendimiento, de salid, de humor… De lo que quiera! Estoy encantada 👍
Soy muy de podcasts. Mientras hago la cama, mientras recojo la casa, mientras trabajo… Y en Podimo encuentro podcast que me encantan. De emprendimiento, de salid, de humor… De lo que quiera! Estoy encantada 👍
MI TOC es feliz, que maravilla. Ordenador, limpio, sugerencias de categorías nuevas a explorar!!!
Me suscribi con los 14 días de prueba para escuchar el Podcast de Misterios Cotidianos, pero al final me quedo mas tiempo porque hacia tiempo que no me reía tanto. Tiene Podcast muy buenos y la aplicación funciona bien.
App ligera, eficiente, encuentras rápido tus podcast favoritos. Diseño sencillo y bonito. me gustó.
contenidos frescos e inteligentes
La App va francamente bien y el precio me parece muy justo para pagar a gente que nos da horas y horas de contenido. Espero poder seguir usándola asiduamente.

Elige tu suscripción

Más populares

Oferta limitada

Premium

20 horas de audiolibros

  • Podcasts solo en Podimo

  • Disfruta los shows de Podimo sin anuncios

  • Cancela cuando quieras

2 meses por 1 €
Después 4,99 € / mes

Empezar

Premium Plus

100 horas de audiolibros

  • Podcasts solo en Podimo

  • Disfruta los shows de Podimo sin anuncios

  • Cancela cuando quieras

Disfruta 30 días gratis
Después 9,99 € / mes

Prueba gratis

Sólo en Podimo

Audiolibros populares

Empezar

2 meses por 1 €. Después 4,99 € / mes. Cancela cuando quieras.